Literature DB >> 6684115

Forskolin-activated adenylate cyclase. Inhibition by guanyl-5'-yl imidodiphosphate.

T H Hudson, J N Fain.   

Abstract

Forskolin activated adenylate cyclase of purified rat adipocyte membranes in the absence of exogenous guanine nucleotides. Guanyl-5'-yl imidodiphosphate (Gpp(NH)p) inhibited the forskolin-activated cyclase immediately upon addition of the nucleotide at concentrations too low to activate adenylate cyclase (10(-9) to 10(-7) M). Inhibition seen with a very high concentration of Gpp(NH)p (10(-4) M) lasted for 3-4 min and was followed by an increase in the synthetic rate which remained constant for at least 15 min. The length of the transient inhibition did not vary with forskolin concentrations above 0.05 microM but low Gpp(NH)p (10(-8) M) exhibited a lengthened (6-7 min) inhibitory phase. The transient inhibitory effects of Gpp(NH)p were eliminated by 10(-7) M isoproterenol, high (40 mM) Mg2+, or preincubation with Gpp(NH)p in the absence of forskolin. While forskolin stimulated fat cell cyclase in the presence of Mn2+, this ion blocked the inhibitory effects of Gpp(NH)p. The well documented inhibitory effects of GTP on the fat cell adenylate cyclase system were also observed in the presence of forskolin. However, the inhibition by GTP is not transitory. These findings indicate that Gpp(NH)p regulation of forskolin-stimulated cyclase has at least two components: 1) an inhibitory component which acts through an undetermined mechanism and which acts immediately to decrease cyclase activity; and 2) an activating component which modulates the inhibited cyclase activity through the guanine nucleotide regulatory protein.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6684115

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Adenylate cyclase induces intracellular Ca2+ increase in single human epidermal keratinocytes of the epidermal sheet as measured by digital imaging microscopy using Fura 2-AM.

Authors:  Y Osawa; H Koizumi; T Fukaya; C Yasui; A Ohkawara; T Ueda
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

2.  Dual regulation of neutrophil adenylate cyclase by fluoride and its relationship to cellular activation.

Authors:  M Saad; C F Strnad; K Wong
Journal:  Br J Pharmacol       Date:  1987-08       Impact factor: 8.739

3.  Forskolin increases osmotic water permeability of rabbit cortical collecting tubule.

Authors:  M A Dillingham; J K Kim; M F Horster; R J Anderson
Journal:  J Membr Biol       Date:  1984       Impact factor: 1.843

4.  Interactive effects of isoprenaline, forskolin and acetylcholine on Ca2+ current in frog ventricular myocytes.

Authors:  R Fischmeister; A Shrier
Journal:  J Physiol       Date:  1989-10       Impact factor: 5.182

5.  Regulation of Ca2+ current in frog ventricular cardiomyocytes by 5'-guanylylimidodiphosphate and acetylcholine.

Authors:  T D Parsons; A Lagrutta; R E White; H C Hartzell
Journal:  J Physiol       Date:  1991-01       Impact factor: 5.182

6.  Demonstration of inhibitory guanine nucleotide regulatory protein (Gi) function in liver and hepatocyte membranes from streptozotocin-treated rats.

Authors:  D M Kirkham; G J Murphy; P Young
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

7.  Pharmacology and inotropic potential of forskolin in the human heart.

Authors:  M R Bristow; R Ginsburg; A Strosberg; W Montgomery; W Minobe
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

8.  The tumor suppressor RASSF10 is upregulated upon contact inhibition and frequently epigenetically silenced in cancer.

Authors:  A M Richter; S K Walesch; P Würl; H Taubert; R H Dammann
Journal:  Oncogenesis       Date:  2012-06-25       Impact factor: 7.485

9.  Mechanism of muscarinic receptor-induced K+ channel activation as revealed by hydrolysis-resistant GTP analogues.

Authors:  G E Breitwieser; G Szabo
Journal:  J Gen Physiol       Date:  1988-04       Impact factor: 4.086

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.